Niche CRO focus BASi Research Products operates in contract research services and niche instrumentation for life sciences, targeting drug research, discovery, and development in both commercial and academic settings. This presents a sales opportunity to offer specialized CRO capabilities and high-value analytical instrumentation to pharma, biotech, and academic labs seeking focused nonclinical testing and DMPK insights.

Acquisitions expanding scope Since 2018 BASi expanded through acquisitions that branched into two divisions, Inotiv and BASi Research Products, broadening capabilities in contract research services and instrumentation. This indicates potential cross-sell opportunities across the enlarged product and service portfolio, including integration of combined CRO and analytical tools.

Senior leadership hires Frequent senior leadership additions in areas like operations, pathology, HR, DMPK, and surgical models suggest ongoing strategic growth and capability enhancement. Sales outreach can emphasize BASi’s strengthened leadership, expanded service lines, and commitment to scaling specialized research capabilities.

Global lab network As a global provider with clients including large pharma, academia, startups, and biotech, BASi serves diverse research settings. This breadth signals opportunities to package turnkey, end-to-end research solutions combining nonclinical testing, immunochemistry, electrochemistry, and toxicology with instrumentation sales.

Growth-ready revenue range With revenue in the one to ten million range and a lean employee base, BASi appears positioned for targeted, high-margin opportunities, especially by offering scalable services, pilot studies, and instrument leasing or bundled CRO-instrumentation packages to accelerate client drug development programs.